New Age Beverages Corp (NBEV)
$2.72
0.05 (1.88%)
NBEV Stock Quote Delayed 15 Minutes
Previous Close
$2.67
Market Cap
107.15M
PE Ratio
-16.97
EPS
-0.16
Volume (Avg. Vol.)
680,127
Day's Range
2.58 - 2.73
52-Week Range
2.57 - 7.79
Dividend & Yield
N/A (N/A)
NBEV Stock Predictions, Articles, and New Age Beverages Corp News
Stock Market Today: Trade Talks Start; Cannabis Stocks Burned
Cannabis stocks were torched Thursday, while trade talks continue. Here's what happened in the stock market today.
The Good News and the Bad News for New Age Beverages Stock
New Age Beverages is the real deal, but a disconnect between it and NBEV stock ended up punishing many unsuspecting investors.
How to Trade Cronos Group Stock as More Support Fails
While cannabis investments like Cronos Group stock have done well earlier in the game, this sector has lost significant credibility. As such, you don’t want to spend too much money on CRON, which is both technically and fundamentally weak.
Low-Priced Stocks for Bears and Bulls: Nio Stock and NBEV
As a rule, lower-priced stocks are priced that way for a reason. Still, that doesn’t mean you can’t turn a profit trading short, as well as long, in Nio stock and NBEV.
Four Reasons Why New Age Beverages Stock Could Be A Multi-Bagger
The outlook on New Age Beverages is simple. NBEV stock could rise by 400% over the next five years... or end up as a penny stock.
Too Many Questions Surround NBEV Stock
NBEV stock has faded in 2019 - for good reason. Serious questions surround both M&A and execution.
Why the Vaping Crisis Might Benefit CBD-infused New Age Beverages Stock
NBEV stock could be a contrarian play amid the vaping crisis as New Age Beverages makes more-acceptable CBD-infused drinks.
Especially Under Current Conditions, Stay Far Away from Hexo Stock
Hexo stock is too dangerous to deal with right now, even though the company is doing everything it's supposed to be doing at a manageable pace.
Worries Mount as Aurora Cannabis Stock Nears 52-Week Lows
Like other cannabis investments, Aurora Cannabis stock has suffered incredible volatility recently. In order to generate some confidence, ACB stock must start justifying its rich premium.
Why New Age Beverages Stock Is High-Risk, High-Reward
NBEV stock is a potential multi-bagger in the long run... but the pathway to 100%-plus returns lacks visibility and tangibility.
5 Top Stock Trades for Monday: INTC, TWTR, AMZN, APHA, UBER
Intel, Amazon, Aphria, Uber and Twitter were our top stock trades on Friday, as big moves from earnings and otherwise setup big moves.
Cronos Needs to Show the Market Something to Pull Stock Out of Funk
CRON stock is putting pressure on the 200-day moving average line, as a floor, and Cronos Group can to little to relieve it.
The Buzz May Be Over for New Age Beverages Stock for Awhile
These companies seem much better positioned than NBEV and would likely make better investment opportunities than NBEV stock.
The Blue Chip of Pot: Can CGC Stock Rally 20% on Acreage Deal and Earnings?
CGC stock will report earnings on June 20th, just a day after it got the OK from shareholders for its $3.4 billion deal for Acreage Holdings.
New Age Beverages News: NBEV Stock Climbs on CBD Products Launch
New Age Beverages news for Tuesday about the launch of some new products in China nd Hong Kong containing CBD oil has NBEV stock up.
Diversification Is What Makes Aurora Stock a Solid Marijuana Play
ACB stock is still a very speculative name, but Aurora Cannabis' management has proven to be wise, and savvy.
NBEV Stock Is More Than Just CBD — But It’s Still Not Enough
New Age Beverages has made some good moves since drawing attention for CBD drinks, but its high valuation gives NBEV stock a sell-by date.
CBD Products May Offer the Competitive Edge to Move Kroger Stock Higher
Recent reports say that Kroger will start selling CBD products at almost 1,000 of its stores. Will it be enough to boost Kroger stock?
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
